Genetic evaluation based on family history and Her2 status correctly identifies TP53 mutations in very early onset breast cancer cases

Publisher： John Wiley & Sons Inc

E-ISSN： 1399-0004|87|4|383-387

ISSN： 0009-9163

Source： CLINICAL GENETICS, Vol.87, Iss.4, 2015-04, pp. : 383-387

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Germline TP53 mutations is common in patients with two early‐onset primary malignancies

By  

CLINICAL GENETICS, Vol. 87, Iss. 5, 2015-05 ,pp. : 499-501

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Consequence of Oncomorphic TP53 Mutations in Ovarian Cancer

By Brachova Pavla   Thiel Kristina W.   Leslie Kimberly K.  

International Journal of Molecular Sciences, Vol. 14, Iss. 9, 2013-09 ,pp. : 19257-19275

MDPI

Access to resources Recommend Favorite

Novel biallelic SZT2 mutations in 3 cases of early‐onset epileptic encephalopathy

By  

CLINICAL GENETICS, Vol. 93, Iss. 2, 2018-02 ,pp. : 266-274

John Wiley & Sons Inc

Access to resources Recommend Favorite

Integrated MicroRNA–mRNA Profiling Identifies Oncostatin M as a Marker of Mesenchymal-Like ER-Negative/HER2-Negative Breast Cancer

By Bottai Giulia   Diao Lixia   Baggerly Keith A.   Paladini Laura   Győrffy Balázs   Raschioni Carlotta   Pusztai Lajos   Calin George A.   Santarpia Libero  

International Journal of Molecular Sciences, Vol. 18, Iss. 1, 2017-01 ,pp. : 194-194

MDPI

Access to resources Recommend Favorite

Evaluation of HER2 Gene Amplification in Breast Cancer Using Nuclei Microarray in Situ Hybridization

By Jiang Huiyong   Bai Xiaoyan   Zhang Cheng   Zhang Xuefeng  

International Journal of Molecular Sciences, Vol. 13, Iss. 5, 2012-05 ,pp. : 5519-5527

MDPI

Access to resources Recommend Favorite